These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 8525613

  • 1. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
    Parkinson JE, Sanderson CM, Smith GL.
    Virology; 1995 Dec 01; 214(1):177-88. PubMed ID: 8525613
    [Abstract] [Full Text] [Related]

  • 2. Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence.
    Price N, Tscharke DC, Hollinshead M, Smith GL.
    Virology; 2000 Feb 01; 267(1):65-79. PubMed ID: 10648184
    [Abstract] [Full Text] [Related]

  • 3. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE, Smith GL.
    Virology; 1994 Oct 01; 204(1):376-90. PubMed ID: 8091668
    [Abstract] [Full Text] [Related]

  • 4. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Engelstad M, Smith GL.
    Virology; 1993 Jun 01; 194(2):627-37. PubMed ID: 8503178
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells.
    Sanderson CM, Parkinson JE, Hollinshead M, Smith GL.
    J Virol; 1996 Feb 01; 70(2):905-14. PubMed ID: 8551630
    [Abstract] [Full Text] [Related]

  • 6. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
    Ortiz MA, Paez E.
    Virology; 1994 Jan 01; 198(1):155-68. PubMed ID: 8259650
    [Abstract] [Full Text] [Related]

  • 7. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
    Fischer SF, Ludwig H, Holzapfel J, Kvansakul M, Chen L, Huang DC, Sutter G, Knese M, Häcker G.
    Cell Death Differ; 2006 Jan 01; 13(1):109-18. PubMed ID: 16003387
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the vaccinia virus A35R protein and its role in virulence.
    Roper RL.
    J Virol; 2006 Jan 01; 80(1):306-13. PubMed ID: 16352555
    [Abstract] [Full Text] [Related]

  • 9. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles.
    van Eijl H, Hollinshead M, Smith GL.
    Virology; 2000 May 25; 271(1):26-36. PubMed ID: 10814567
    [Abstract] [Full Text] [Related]

  • 10. The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface.
    Wilcock D, Duncan SA, Traktman P, Zhang WH, Smith GL.
    J Gen Virol; 1999 Aug 25; 80 ( Pt 8)():2137-2148. PubMed ID: 10466813
    [Abstract] [Full Text] [Related]

  • 11. Intracellular processing of pseudorabies virus glycoprotein M (gM): gM of strain Bartha lacks N-glycosylation.
    Dijkstra JM, Mettenleiter TC, Klupp BG.
    Virology; 1997 Oct 13; 237(1):113-22. PubMed ID: 9344913
    [Abstract] [Full Text] [Related]

  • 12. Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99).
    Cranmer LD, Clark C, Spector DH.
    Virology; 1994 Dec 13; 205(2):417-29. PubMed ID: 7975245
    [Abstract] [Full Text] [Related]

  • 13. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence.
    Reading PC, Khanna A, Smith GL.
    Virology; 2002 Jan 20; 292(2):285-98. PubMed ID: 11878931
    [Abstract] [Full Text] [Related]

  • 14. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 20; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 15. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
    Gurt I, Abdalrhman I, Katz E.
    Antiviral Res; 2006 Mar 20; 69(3):158-64. PubMed ID: 16406098
    [Abstract] [Full Text] [Related]

  • 16. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene.
    Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B.
    Virology; 1993 Aug 20; 195(2):732-44. PubMed ID: 8337842
    [Abstract] [Full Text] [Related]

  • 17. A novel Epstein-Barr virus glycoprotein gp150 expressed from the BDLF3 open reading frame.
    Kurilla MG, Heineman T, Davenport LC, Kieff E, Hutt-Fletcher LM.
    Virology; 1995 May 10; 209(1):108-21. PubMed ID: 7747461
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.
    Stern RJ, Thompson JP, Moyer RW.
    Virology; 1997 Jun 23; 233(1):118-29. PubMed ID: 9201221
    [Abstract] [Full Text] [Related]

  • 19. The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutant.
    Martinez R, Shao L, Bronstein JC, Weber PC, Weller SK.
    Virology; 1996 Jan 15; 215(2):152-64. PubMed ID: 8560762
    [Abstract] [Full Text] [Related]

  • 20. Characterization of vaccinia surface antigen expressed by recombinant baculovirus.
    Morikawa S, Ueda Y.
    Virology; 1993 Apr 15; 193(2):753-61. PubMed ID: 8460484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.